Developing effective immunotherapies for acute myeloid leukemia (AML) has long been hampered by a critical challenge: Therapy ...
The suspects in an alleged gambling ring operated out of Northwest Indiana, including a well-known restaurateur, are scheduled to face a judge Thursday morning. In a case that law enforcement ...
COPENHAGEN, Denmark, May 12, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, will announce the ...
Acute myeloid leukemia (AML) is one of the most aggressive blood cancers and is characterized by the rapid growth of immature ...
In fact, once Health Canada approves a drug, the process should skip Canada’s Drug Agency entirely. The CDA is a bureaucratic ...
The addition of an off-the-shelf pooled stem cell product to a single unit of umbilical cord blood conferred favorable ...
Regulatory clearance creates an at-home, 28-day cycle option using oral decitabine/cedazuridine on days 1–5 plus venetoclax 400 mg daily after a ramp-up cycle. Efficacy signals in ASCERTAIN-V included ...
New research out of VCU Massey Comprehensive Cancer Center has uncovered a targeted cancer therapy that significantly prevents leukemia progression, improves survival rates and minimizes damage to ...
Distinct Biology Driving Different Treatment Needs: Advances in genomic profiling reveal that pediatric leukemias are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results